Storage Stability
Growth differentiation factor 9 (GDF-9) is a TGF-beta superfamily member produced exclusively by oocytes from primary follicle stage onward. It is the critical paracrine signal that drives granulosa cell proliferation, cumulus cell expansion, and normal folliculogenesis. GDF-9 is essential for female fertility, and loss-of-function mutations cause premature ovarian insufficiency (POI) and infertility in humans and mice.
Mechanism of Action
- Signals through a non-canonical TGF-beta receptor complex (BMPR2/ALK5) using SMAD2/3 rather than SMAD1/5/8 used by BMPs
- Stimulates granulosa cell proliferation and suppresses apoptosis via SMAD2/3 and PI3K/Akt signaling
- Induces cumulus cell expansion by upregulating hyaluronan synthase (HAS2) and pentraxin-3 (PTX3), essential for the cumulus oocyte complex (COC)
- Suppresses FSH receptor expression in mural granulosa cells (differentiation suppression) while stimulating proliferation (KIT ligand induction)
- Cooperates with bone morphogenetic protein 15 (BMP15) via synergistic heterodimer formation; GDF-9:BMP15 heterodimer is 3-10x more potent than either homodimer
Research Findings
- GDF-9 knockout mice: female infertile due to follicular arrest at primary follicle stage; male fertile; establishes GDF-9 as essential for folliculogenesis beyond primary stage
- Human GDF-9 mutations (Y235C, S427P) identified in women with premature ovarian insufficiency (POI) and dizygotic twinning propensity
- Women with high ovarian reserve (higher AMH, more antral follicles) have elevated GDF-9 expression per oocyte vs diminished reserve
- Recombinant GDF-9 or BMP15-GDF-9 heterodimer added to IVF culture media improved embryo development in some pilot studies
- GDF-9:BMP15 coreceptor heterodimer concept explains why BMP15 mutations in sheep cause infertility only in homozygotes (Booroola phenotype)
Research Protocols
- Granulosa cell proliferation: 1-100 ng/mL recombinant GDF-9 on primary granulosa cells; Ki67 staining or [3H]-thymidine incorporation
- Cumulus expansion assay: GDF-9 + FSH on in vitro cumulus-oocyte complex culture; assess HAS2 expression and viscoelastic matrix formation
- IVF culture supplement: 1-10 ng/mL GDF-9 added to IVF media during oocyte maturation and embryo culture stages
- Mouse folliculogenesis: GDF-9 neutralizing antibody in vivo in mice; quantify antral follicle development at 14 days
Interactions
- BMP15: synergistic paracrine partner; GDF-9:BMP15 heterodimer 3-10x more potent than either homodimer; co-expressed by oocytes
- BMPR2/ALK5: non-canonical BMP signaling complex; BMPR2 mutations affect GDF-9 response in granulosa cells
- FSH: GDF-9 and FSH have complex interactions; GDF-9 suppresses FSHRexpression in mural GC while amplifying FSH effects in cumulus GC
Safety Profile
Endogenous oocyte-derived growth factor. Not approved as therapeutic. Recombinant GDF-9 studied only in in vitro fertilization contexts; no systemic administration safety data. IVF culture supplement studies show no detectable adverse embryo effects.
Legal & Regulatory
Research reagent; IVF culture supplement in investigational use
Ready to dose GDF-9?
Get the exact syringe draw
You have read the research. Now run the math. Pick your vial size and BAC water volume, get IU draw in seconds.
Open the Calculator →
Categories:
Endogenous PeptideTGF-beta SuperfamilyOocyte FactorReproductive BiologyFolliculogenesisFemale Fertility
More in Hormonal & Reproductive
View all →